Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

UNIVERSITY OF CHICAGO Chicago IL 60637 USA

UEI: SLED_6D7EF4695EA4C76F

UNIVERSITY OF CHICAGO Chicago IL 60637 USA is a federal contractor, registered under UEI SLED_6D7EF4695EA4C76F. It has been awarded $9,807,060 in federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_6D7EF4695EA4C76F

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The University of Chicago provides specialized research and technical services, with demonstrated capabilities in research and development within the scientific and technical fields. The organization maintains a working relationship with the Department of Health and Human Services, where it execute...

The University of Chicago provides specialized research and technical services, with demonstrated capabilities in research and development within the scientific and technical fields. The organization maintains a working relationship with the Department of Health and Human Services, where it executes cost-reimbursement contracts to support agency objectives. The contractor operates primarily under NAICS 541714, focusing on research and development in the physical, engineering, and life sciences.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with UNIVERSITY OF CHICAGO Chicago IL 60637 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for UNIVERSITY OF CHICAGO Chicago IL 60637 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in UNIVERSITY OF CHICAGO Chicago IL 60637 USA's top NAICS codes and agencies

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
DNA Sequencing Service
Solicitation # 75N98027Q00090
The National Institutes of Health (NIH) is soliciting a Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract for high-throughput DNA sequencing services, including Sanger DNA sequencing and whole-plasmid sequencing. The scope of work involves processing plasmid DNA, genomic DNA, and PCR-generated material, with requirements for PCR amplification, product purification, and DNA normalization. The contractor is responsible for providing all sample collection and shipping materials, maintaining strict confidentiality of sequencing data, and retaining DNA samples for at least 180 days post-sequencing. Deliverables include specific electronic file formats such as .ab1, .fasta, and raw FASTQ data, alongside a Monthly Status Report submitted to the Contracting Officer's Representative (COR). The contract spans a five-year period from January 4, 2027, to January 3, 2032, with a total estimated value ranging from $184,200.00 to $958,584.20. Performance and delivery are centered at the NIEHS facility in Research Triangle Park, North Carolina. Award selection will be based on a best value tradeoff, where technical capability and past performance are weighted more heavily than price. Technical evaluations will focus on sequencing capability, personnel qualifications, quality assurance/control, and data management. The acquisition is not set aside for small businesses and falls under NAICS code 541714.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 19 days
View Details
NAICS: 541714
New
Federal
FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Solicitation # FDABAA-27-00123
The FY27 FDA Broad Agency Announcement (FDABAA-27-00123) is a solicitation by the Department of Health and Human Services, Food and Drug Administration (FDA), for basic and applied research and development proposals to support regulatory science and innovation. The BAA identifies 22 priority research areas, including updated interests in nonclinical development such as human tooth enamel evaluation techniques. Per Executive Order 14434, the agency has transitioned the terminology from Artificial Intelligence to Super Intelligence within the tobacco and nicotine research section. The solicitation is open to all responsible sources, including academic institutions and small businesses, with awards issued via procurement contracts. Proposals must follow a two-tiered submission process consisting of a checklist, a three-page concept paper, and a full technical proposal, all submitted as a single PDF not exceeding 2 megabytes. The deadline for these submissions is January 22, 2027. Evaluation is based on a peer-review process focusing on innovation, technical soundness, scope understanding, and the significance of the problem addressed. Successful offerors must adhere to Good Manufacturing Practice Regulations and provide monthly technical progress reports. All applicants are required to maintain active SAM.gov registration and disclose any potential organizational conflicts of interest.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Federal
AUTOIMMUNE DISEASES STATISTICAL & CLINICAL COORDINATING CENTER (AD-SCCC)
Solicitation # 75N93026R00009
The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) is seeking to extend the contract for the Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC). This project provides essential support for the design, development, execution, and analysis of clinical research focused on autoimmune diseases, mucosal immunology, and primary immune deficiencies. The scope of work includes supporting the Autoimmunity Centers of Excellence and Immune Tolerance Network (ACE) and investigator-initiated clinical trials (IICT). Key responsibilities encompass statistical design and analysis, protocol development, data management, clinical safety and pharmacovigilance support, and the management of biological specimen repositories and collaboration portals. The NIAID intends to negotiate a sole source modification with Rho Federal Systems Division, Inc. under FAR Part 6.302-1 and HHSAR Part 306.302-1 to avoid significant disruptions to critical services and ensure participant safety and data integrity. The proposed 18-month extension is structured as two discrete option periods: a 12-month period from February 1, 2027, through January 31, 2028, and a 6-month period through July 31, 2028. This extension maintains the existing term type/level of effort contract structure and scope to ensure continuity of operations while the agency completes a separate competition process.
National Institutes Of Health Niaid

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 541715
New
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance medical interventions for infectious diseases. The initiative is divided into three primary research areas: Research Area 001 focuses on developing vaccine candidates using needle-free delivery routes through early-phase clinical trials; Research Area 002 targets the development of safe and effective therapeutic products, such as small molecules or monoclonal antibodies, for serious infectious diseases that are refractory to current treatments; and Research Area 003 seeks innovative in vitro diagnostic technology platforms capable of rapid, automated detection and identification of priority viral pathogens, preferably with a sample-to-answer time of less than two hours. The NIAID estimates up to 16 million dollars in funding for Fiscal Year 2027, utilizing cost-reimbursement completion-type contracts with performance periods of up to five years. Proposals must be submitted electronically via the eCPS portal by December 8, 2026, at 3:00 PM Eastern Time. Awards will be based on technical merit as the paramount consideration, followed by cost realism, with a requirement that proposals be deemed technically acceptable by a peer review group. All submissions must adhere to strict formatting guidelines, including a 75-page limit for technical proposals and compliance with HHS EIT accessibility and Section 508 standards.
National Institutes Of Health Niaid

POSTED

2 days ago

DEADLINE

in 20 days
View Details